short stature, photosensitivity and reduced sweating and was diagnosed as Tay's syndrome.
A biopsy showed hyperkeratosis, hypergranulosis, mild acanthosis and follicular plugging over the treated site and the site treated with liquid paraffin showed hyperkeratosis, parakeratosis, acanthosis, neutrophil collections in the stratum corneum and neutrophil infiltrate around the blood vessels in the superficial dermis. He was initially treated with isotretinoin 20 mg for one month and responded partially to the treatment but was unwilling to continue because of the possible side-effects. He was then advised to apply tazarotene 0.1% twice daily on the left side of the entire back and liquid paraffin twice daily on the right side of the back. In two weeks significant improvement with reduction in erythema and scaling was seen on the tazarotene treated site as compared to the site 4. 7. 8.
9.
Tay's syndrome, a rare autosomal recessive disorder reported by Dr. Tay Chong Hai in Singapore in the year 1969, is characterized by icthyosiform erythroderma, trichothiodystrophy, brittle hair and nails, intellectual impairment, decreased fertility, short stature, progerialike facies and photosensitivity. [1] Emollients are helpful in improving skin discomfort and suppleness. Retinoid therapy and keratolytics have been tried with disappointing results. [1] We report control of ichthyosis in a case of Tay's syndrome by topical application of tazarotene.
A 17-year-old male presented with trichorrhexis nodosa (diagnosed with light microscopy), ichthyosiform erythroderma Letters to the Editor treated with liquid paraffin [ Figure 2 ]. Since 0.1% tazarotene although effective resulted in a few areas of irritation 0.05% was tried but was less effective. The patient and the parents then decided to apply tazarotene 0.1% over the face only and this resulted in clearing of face lesions but with relapse of lesions over the trunk.
Tazarotene is used in the treatment of psoriasis [2] and acne vulgaris. [3] In single cases or small series, useful responses to topical application of tazarotene have been reported is a prodrug that is hydrolyzed rapidly in tissues to the active metabolite termed tazarotenic acid. Tazarotenic acid has a high affinity to the RAR-γ nuclear receptor that is the predominant receptor present in the epidermis. Tazarotenic acid also binds to RAR-α and RAR-β not to RXRs. By binding to
Basal cell carcinoma developing Basal cell carcinoma developing the various RARs, tazarotenic acid modulates the expression of retinoid responsive genes, including those that regulate in verrucous epidermal nevus in verrucous epidermal nevus cell proliferation, cell differentiation and inflammation. Thus the topical application of tazarotene resulted in decrease of erythema and scaling. Sir,
Since the patient has congenital ichthyosis, he was advised Epidermal nevi increase slowly in size during childhood to apply tazarotene daily, as alternate day-tapering resulted and become stationary at puberty. [1] Both basal cell and in relapse. We recommend the use of topical tazarotene as squamous cell carcinomas have been reported to develop a safe alternative in the treatment of ichthyosis associated in an epidermal nevus; these are however extremely rare. There was single well-defined ulcer (6×6 cm) with a regular outline, elevated rolled edge and a firm base with crusting and bleeding in a few areas [ Figure 1 ]. It was not fixed and there was no local lymphadenopathy. A diagnosis of basal cell carcinoma arising in a verrucous epidermal nevus was made. Biopsy from the margin of the ulcer revealed basaloid tumor with cells arranged in an infiltrative pattern with retraction spaces [ Figure 2 ]. Mild pleomorphism, hyperchromatosis, inconspicuous nucleoli and scanty cytoplasm were also noted. Focal keratin pearls, desmoplastic reaction and myxoid change could also be seen. Sebaceous glands were scanty. These findings were suggestive of basal cell carcinoma (BCC).
